Abstract

Clonidine 0.01-mg/mL in Ora-Blend Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5

Page(s): 414

Download in electronic PDF format for $75
  • Clonidine 0.01-mg/mL in Ora-Blend Suspension Page 1

Abstract

A formulation for preparing Clonidine 0.01-mg/mL in Ora-Blend Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • clonidine
  • central acting alpha 2 adrenergic agonist
  • sympathetic nervous system
  • formulation
  • oral suspension
  • opioid withdrawal
  • benzodiazepine withdrawal
  • alcohol withdrawal
  • high blood pressure
  • hypertension
  • antihypertensive agent
  • anxiety disorders
  • tic disorders
  • migraine
  • menopause
  • hot flashes
  • vasomotor symptoms
  • diarrhea
  • pain syndromes

Related Categories

  • FORMULATIONS
  • MENTAL HEALTH
  • PAIN MANAGEMENT
  • CARDIOLOGY
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2021
Pg. 414
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 146
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2022
Pg. 148
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 413
Cilazapril 1-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2002
Pg. 66-69
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes
Author(s): Xu Quanyun A, Trissel Lawrence A, Pham Lien
Nov/Dec 2018
Pg. 496
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Author(s): Allen Loyd V Jr
Jan/Feb 1999
Pg. 25-29
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 52
Metronidazole 50 mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 429
Lansoprazole 3-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Nov/Dec 2016
Pg. 512
Melatonin 2-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 71
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 506
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 43
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 57
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 411
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Author(s): Allen Loyd V Jr